CANNAPHARMARX, INC. (CPMD) Total liabilities 2016–2025
CANNAPHARMARX, INC. (CPMD) total liabilities at each fiscal year-end, per SEC filings.
$37.2MFY2025 · since FY2016: $959,333 → $37.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.2M | +21.3% |
| FY2024 | $30.6M | +28.2% |
| FY2023 | $23.9M | +5.0% |
| FY2022 | $22.8M | +74.5% |
| FY2021 | $13.0M | -25.7% |
| FY2020 | $17.5M | +57.2% |
| FY2019 | $11.2M | +7.5% |
| FY2018 | $10.4M | +976.9% |
| FY2017 | $964,300 | +0.5% |
| FY2016 | $959,333 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPMD financial trends
CPMD RevenueCPMD Net incomeCPMD Net marginCPMD Gross profitCPMD Gross marginCPMD Operating incomeCPMD Operating marginCPMD Operating cash flowCPMD Free cash flowCPMD Capital expendituresCPMD Return on equityCPMD Stock buybacksCPMD Dividends paidCPMD Total assetsCPMD Shareholders’ equityCPMD overview →